Roche's Virtual Late Stage Pipeline Event 2018 Replay
Roche has hosted a live video webcast and conference call on Thursday, 13 September 2018.
Agenda
- Pharma strategy
Daniel O’Day, CEO Roche Pharmaceuticals - Late stage NMEs in oncology, ophthalmology and infectious diseases
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development - Late stage NMEs in neuroscience
Paulo Fontoura, M.D. Ph.D., Head of Neuroscience Clinical Development - Commercial opportunities
Alexander Hardy, Head of Global Product Strategy